Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK/PD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03959514
What this trial is testing

AT247, NovoRapid® and Fiasp® in Glucose Clamp Study

Who this might be right for
Diabetes Mellitus, Type 1
Arecor Limited 18
Testing effectiveness (Phase 2)Study completedNCT01158755
What this trial is testing

Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study

Who this might be right for
Meningitis, TuberculousPharmacokineticsPharmacodynamics+1 more
Universitas Padjadjaran 60
Early research (Phase 1)Study completedNCT03588923
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of SH229 in Patients With HCV Infection

Who this might be right for
HCV Infection
Nanjing Sanhome Pharmaceutical, Co., Ltd. 30
Early research (Phase 1)Study completedNCT01292655
What this trial is testing

Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
Bristol-Myers Squibb 94
Early research (Phase 1)Study completedNCT05186285
What this trial is testing

Single Ascending Dose Study of CM338 in Healthy Volunteers

Who this might be right for
Healthy
Keymed Biosciences Co.Ltd 66
Early research (Phase 1)Study completedNCT02616874
What this trial is testing

Study to Evaluate the Safety and Effect of HIVconsv Vaccines in Combination With Histone Deacetylase Inhibitor Romidepsin on the Viral Rebound Kinetic After Treatment Interruption in Early Treated HIV-1 Infected Individuals

Who this might be right for
HIV
IrsiCaixa 15
Early research (Phase 1)Study completedNCT05011097
What this trial is testing

A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Wuhan YZY Biopharma Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT00481520
What this trial is testing

Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 72
Testing effectiveness (Phase 2)Study completedNCT01284062
What this trial is testing

Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients

Who this might be right for
Colitis, Ulcerative
Pfizer 84
Early research (Phase 1)Study completedNCT01903824
What this trial is testing

Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects

Who this might be right for
Cognitive Impairment
Teva Branded Pharmaceutical Products R&D, Inc. 40
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07228325
What this trial is testing

Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis

Who this might be right for
AnaphylaxisAllergy
Nasus Pharma 50
Early research (Phase 1)Study completedNCT01036035
What this trial is testing

Effects of Novel Combinations of Tolterodine/Pilocarpine on Pharmacokinetics (PK) and Pharmacodynamics (PD) of Tolterodine in Healthy Subjects

Who this might be right for
Incontinence
TheraVida, Inc. 18
Early research (Phase 1)Study completedNCT00434746
What this trial is testing

Study of the Safety, Tolerability, PK, and PD of ILV-094 Administered IV or SC to Healthy Subjects

Who this might be right for
Healthy
Wyeth is now a wholly owned subsidiary of Pfizer 56
Early research (Phase 1)Study completedNCT06350279
What this trial is testing

A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK39297 in Healthy Subjects

Who this might be right for
Healthy
Haisco Pharmaceutical Group Co., Ltd. 96
Early research (Phase 1)Active Not RecruitingNCT05422482
What this trial is testing

Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123 in Patients with MPS Ⅱ

Who this might be right for
Mucopolysaccharidosis IIHunter Syndrome
GC Biopharma Corp 12
Early research (Phase 1)Looking for participantsNCT06657768
What this trial is testing

LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

Who this might be right for
Alzheimer DiseaseHealthy
Eli Lilly and Company 128
Testing effectiveness (Phase 2)Study completedNCT00768560
What this trial is testing

Nifedipine (Adalat CR, BAY A1040) High Dose PK/PD Study

Who this might be right for
Hypertension
Bayer 35
Early research (Phase 1)Looking for participantsNCT07304791
What this trial is testing

This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of BEAM-103 in Healthy Subjects

Who this might be right for
Healthy SubjectsHealthy Participant Study
Beam Therapeutics Inc. 30
Testing effectiveness (Phase 2)Study completedNCT04550325
What this trial is testing

Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19

Who this might be right for
Covid19Pneumonia, Viral
Kamada, Ltd. 12
Very early researchStudy completedNCT04559971
What this trial is testing

Evaluate the Safety, Tolerability, PK and PD of SLN124 in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Silence Therapeutics plc 24
Next Page